CanPredict: a computational tool for predicting cancer-associated missense mutations - PubMed (original) (raw)

. 2007 Jul;35(Web Server issue):W595-8.

doi: 10.1093/nar/gkm405. Epub 2007 May 30.

Affiliations

CanPredict: a computational tool for predicting cancer-associated missense mutations

Joshua S Kaminker et al. Nucleic Acids Res. 2007 Jul.

Abstract

Various cancer genome projects are underway to identify novel mutations that drive tumorigenesis. While these screens will generate large data sets, the majority of identified missense changes are likely to be innocuous passenger mutations or polymorphisms. As a result, it has become increasingly important to develop computational methods for distinguishing functionally relevant mutations from other variations. We previously developed an algorithm, and now present the web application, CanPredict (http://www.canpredict.org/ or http://www.cgl.ucsf.edu/Research/genentech/canpredict/), to allow users to determine if particular changes are likely to be cancer-associated. The impact of each change is measured using two known methods: Sorting Intolerant From Tolerant (SIFT) and the Pfam-based LogR.E-value metric. A third method, the Gene Ontology Similarity Score (GOSS), provides an indication of how closely the gene in which the variant resides resembles other known cancer-causing genes. Scores from these three algorithms are analyzed by a random forest classifier which then predicts whether a change is likely to be cancer-associated. CanPredict fills an important need in cancer biology and will enable a large audience of biologists to determine which mutations are the most relevant for further study.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

The home page of the CanPredict application.

Figure 2.

Figure 2.

The results summary page of the CanPredict application.

Similar articles

Cited by

References

    1. Forbes S, Clements J, Dawson E, Bamford S, Webb T, Dogan A, Flanagan A, Teague J, Wooster R, et al. Cosmic 2005. Br. J. Cancer. 2006;94:318–322. - PMC - PubMed
    1. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science. 2006;312:1228–1230. - PubMed
    1. Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kanetsky PA, Pinkel D, et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science. 2006;313:521–522. - PubMed
    1. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, et al. The consensus coding sequences of human breast and colorectal cancers. Science. 2006;314:268–274. - PubMed
    1. Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C, Bignell G, Teague J, Smith R, et al. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat. Genet. 2005;37:590–592. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources